Hamilton James C reported ARWR

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001830755-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 6, 2026

Published

Jan 8, 2026

Ingested by INSIDER

Nov 5, 04:23 UTC

Last re-read

Nov 5, 04:23 UTC

Extracted facts

Filer

Hamilton James C

Role

Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

ARROWHEAD PHARMACEUTICALS, INC.

Ticker

ARWR

Shares

75.0K

Price per share

$0

Execution date (reported)

Jan 6, 2026

Owned after transaction

247.0K shares

Days from execution to publication

2

What this establishes

Hamilton James C filed this Form 4 reporting a grant or award of ARWR on Jan 6, 2026. It became public on Jan 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Hamilton James Ccik:0001830755

Issuer

ARROWHEAD PHARMACEUTICALS, INC.cik:0000879407

Revision history · 0

No field has changed since this record was first ingested.